{"id":"W4366496702","doi":"10.1016/j.ejca.2023.04.007","title":"Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial","year":2023,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Boehringer Ingelheim","keywords":"Afatinib; Refractory (planetary science); Medicine; Oncology; Internal medicine; Pediatrics; Cancer; Gefitinib; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002367735,0.0001786809,0.0005059654,0.0007748929,0.00003125995,0.00001639042,0.0002369436,0.00003896902,0.0001507811],"category_scores_gemma":[0.0008664818,0.0001283122,0.0001258108,0.001424181,0.0000956751,0.0001404452,0.00006108537,0.0007014537,0.00002825744],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002458627,"about_ca_system_score_gemma":0.000743595,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002676713,"about_ca_topic_score_gemma":0.00001798848,"domain_scores_codex":[0.9962965,0.0006556882,0.001149975,0.0002357662,0.001296658,0.0003654524],"domain_scores_gemma":[0.9976901,0.0001595954,0.0008130929,0.0002823269,0.0007874733,0.0002674597],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4261979,0.002684278,0.03321975,0.0003184357,0.0002369496,0.001929007,0.003640005,0.0003662772,0.003382704,0.000001568794,0.06275176,0.4652713],"study_design_scores_gemma":[0.5075853,0.02856575,0.4148127,0.004074782,0.0002598562,0.000022117,0.0003375973,0.0002136299,0.001683954,0.000007923985,0.04206203,0.0003743337],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956053,0.00125262,0.000005251416,0.0005976361,0.0007867086,0.0005492089,0.00007194346,0.0000216246,0.001109739],"genre_scores_gemma":[0.9974996,0.00101038,0.0001036526,0.00004809588,0.0009379696,0.000004040258,0.00002766481,0.00006544529,0.0003031057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.464897,"threshold_uncertainty_score":0.5232419,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04850224767936248,"score_gpt":0.3747968129093108,"score_spread":0.3262945652299483,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}